News at CenExel

RSV: Perspectives and Insight from a Healthcare Hero

As a former healthcare worker at Primary Children’s Hospital in Salt Lake City, UT, I begin to get more and more concerned about cold and flu season as it pertains to babies, as passing on a simple adult cold to an infant could be dangerous, even life-threatening....

Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™

Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours - ZYNRELEF is the first and only FDA-approved extended-release dual-acting local anesthetic, clinically proven to manage pain and to...

First-In-Human Study of OTO-413

A First-In-Human Study of OTO-413, an Intratympanic Sustained-Exposure Formulation of BDNF, for the Treatment of Speech-in-Noise Hearing Impairment Jeffery J. Anderson(1), James Robinson(1), Alice Blaj(1), Ines Hoffmann(1), Alan Foster(1), Justin Gull(2), Peter...

Translate »